Bannerbild German Brest Group

ESMO 2019

13.03.2018

ESMO 2019

ESMO Breast Cancer is an annual congress taking place for the first time on 2-4 May 2019 in Berlin, Germany.
Brought to you by ESMO, your trusted provider of specialised education in oncology.

More Information

News

  • 03.02.2017 How Much Information Do We Really Need After Neoadjuvant Therapy for Breast Cancer?

    Prof. Loibl and Prof. Denkert discuss "How Much Information Do We Really Need After Neoadjuvant Therapy for Breast Cancer?" in the current JCO Editorial.

    Mehr ...
  • 31.01.2017 Young Investigator Award

    Young Investigator Award

    Die GBG vergibt einen Reise zum ESMO in Madrid in 2017 für junge Wissenschaftler. Bewerbung ab sofort möglich.

    Mehr ...
  • 08.12.2016 The Lancet - Breast Cancer Series 2016

    The introduction of targeted therapies has profoundly changed the course of some subtypes of breast cancer—but many challenges remain. The Lancet’s 2016 Series on breast cancer discusses the most recent advances in the three most common breast cancer subtypes. The first pair of papers focus on the treatment of advanced oestrogen-receptor-positive and HER2-positive breast cancers, while the third describes how an improved understanding of molecular alterations in the heterogeneous and hard-to-treat triple-negative breast cancer may lead to more refined and more effective therapy. http://www.thelancet.com/series/breast-cancer-2016

    Mehr ...

GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd